Anti-CDKN2A/p16INK4a antibody [1D7D2A1]
4
(1 리뷰)
|
(22 제품이 사용된 논문 )
Mouse Monoclonal p16INK4A antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 22 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human CDKN2A.
대체 명칭 보기
CDKN2, MTS1, CDKN2A, Cyclin-dependent kinase inhibitor 2A, Cyclin-dependent kinase 4 inhibitor A, Multiple tumor suppressor 1, p16-INK4a, CDK4I, MTS-1, p16-INK4, p16INK4A
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [1D7D2A1] (AB201980)
Immunohistochemical analysis of paraffin-embedded human endometrial cancer tissues labeling CDKN2A using ab201980 at 1/200 dilution followed by DAB staining.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [1D7D2A1] (AB201980)
Immunohistochemical analysis of paraffin-embedded human esophageal cancer tissues labeling CDKN2A using ab201980 at 1/200 dilution followed by DAB staining.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-CDKN2A/p16INK4a antibody [1D7D2A1] (AB201980)
Flow cytometric analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling CDKN2A using ab201980 at 1/200 dilution (green) compared with a negative control (red).
- WB
Supplier Data
Western blot - Anti-CDKN2A/p16INK4a antibody [1D7D2A1] (AB201980)
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [1D7D2A1] (ab201980) at 1/500 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate
Lane 2:
HepG2 (Human liver hepatocellular carcinoma cell line) cell lysate
Lane 3:
HEK-293 (Human epithelial cell line from embryonic kidney) cell lysate
Predicted band size: 17 kDa
false
- WB
Supplier Data
Western blot - Anti-CDKN2A/p16INK4a antibody [1D7D2A1] (AB201980)
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [1D7D2A1] (ab201980) at 1/500 dilution
All lanes:
recombinant human CDKN2A protein
Predicted band size: 17 kDa
false
- WB
Supplier Data
Western blot - Anti-CDKN2A/p16INK4a antibody [1D7D2A1] (AB201980)
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [1D7D2A1] (ab201980) at 1/500 dilution
Lane 1:
Non-transfected HEK-293 (Human epithelial cell line from embryonic kidney) cell lysate
Lane 2:
CDKN2A (AA: 1-156)-hIgGFc transfected HEK-293 (Human epithelial cell line from embryonic kidney) cell lysate
Predicted band size: 17 kDa
false
Reactivity 정보
제품 세부 정보
특성 및 보관 정보
제형
Purification 테크닉
Purification 관련 사항
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (22)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Cells 14: PubMed40214502
2025
Applications
Unspecified application
Species
Unspecified reactive species
Folia neuropathologica 61:249-265 PubMed37818686
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed37345059
2023
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 29:691-711 PubMed36550594
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:17990 PubMed36289272
2022
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutical biology 59:1388-1401 PubMed34663173
2021
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 14:101199 PubMed34388692
2021
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 13:5866-5879 PubMed34306331
2021
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 13: PubMed34072187
2021
Applications
Unspecified application
Species
Unspecified reactive species
eLife 10: PubMed33983115
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com